Contact
Please use this form to send email to PR contact of this press release:
EpiAxis Therapeutics Enters Strategic Partnership on Prostate Cancer with Canada's University Health Newtork (UHN)
TO:
Dr. Jeremy Chrisp
EpiAxis Therapeutics
+61 421 012 268